VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

CUSIP: G9495L109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Stock
Total 13F shares
57,338
Share change
-1,585,904
Total reported value
$22,763
Price per share
$0.39
Number of holders
4
Value change
-$1,110,521
Number of buys
3
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP G9495L109?
CUSIP G9495L109 identifies VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) as of Q2 2023

As of 30 Jun 2023, VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,338 shares. The largest 4 holders included RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA SECURITIES, LLC, MILLENNIUM MANAGEMENT LLC, and WELLS FARGO & COMPANY/MN. This page lists 4 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.